substrates (b) To build precursors to macromolecules from substrates (c) To assemble precursors into macromolecules. Ex: DNA, Glycogen, Fat (d) To degrade macromolecules into simpler molecules Catabolism and Anabolism Catabolism is the oxidative breakdown of large macromolecules into smaller, simpler compounds. Usually it is accompanied by release of free energy and trapping this energy as ATP Anabolism is the enzymatic synthesis of large macromolecules from smaller, simpler precursors. Usually it requires input of energy. AMPHIBOLIC-has both catab and anab components e.g TCA cycle. Differences between Catab & Anab Enzymes-allows for regulation and direction. Many enzymes may be same in a reversible metabolic pathway but some will differ Energetics- ATP made in Catab; used for Anab Cofactors-NAD NADH used for catabolism NAD(P)HNADP occurs for anabolism Cellular localization may differ e.g cyto vs mito REGULATION of Metabolism
1. Availability & concentration of substrates and COFACTORS. Need to regenerate cofactors 2.Availability/Need for ATP 3. Enzyme characteristics-heme,metal, dimers 4.Regulatory enzymes-often allosteric. ATP catabolic reactions while ADP them. Product inhibiton of anabolic reactions 5. Genetic control of amount of enzyme in cell. Constitutive VS adaptive enzymes. 6. Hormonal regulation- chemical messenger which or a metabolic reaction in another cell.
ENZYME RELATIVE Keq MASS/ACTION ACTIVITY RATIO ____________________________________________________________________
Hexokinase 1 4000 0.08
Phosphoglucoisomerase 117 0.36 0.24
Phosphofructokinase 17 1000 0.03
Aldolase 52 0.0001 0.00001
Triosephosphate isomerase 1768 0.40 0.24
Glyceraldehyde 3P DH 295 1000 900
Phosphoglyceromutase 67 0.10 0.12
Enolase 105 4.0 1.4
Pyruvate Kinase 258 1000 40
CARBOHYDRATES/ GLUCOSE Source of energy: Storage form of energy Produces- fatty acids, cholesterol, steroids, some amino acids e.g serine, glycine, alanine Produces pentoses for RNA and DNA and cofactors e.g NAD, NADP, FAD, Vitamin B12.
Glucose- C6H12O6, a hexose as is fructose. Glucose is an aldose, fructose is a ketose. Ribose is a pentose , glyceraldehyde is a triose. These are monosaccharides. Sucrose is a disaccharide of G and F. lactose is a disaccharide of G and galactose. Polysaccharides made up of many G Glucose transporters and carriers Passive carrier mediated glucose transport: No energy, G moves down its conc. gradient. Blood glucose levels 4-8 mM. GLUT 1 and 3 : Km= 1mM (high affinity), basal G uptake for almost all tissues-RBC, brain, liver, heart etc GLUT 2: Km= 15-20 mM (low affinity), senses high glucose levels. Present in liver & pancreas GLUT 4: present in adipose and muscle. Km = 5 mM. Amount is increased when INSULIN triggers translocation from Golgi to plasma membrane-one major action for insulin Active Transport move molecules against their conc gradient- require ATP or energy source/ gradient GLUT 5: active transport linked to Na+ transport by the Gut and kidney SUMMARY SLIDE! Tissue Affinit y Insulin Reg Pass/Active GLUT1 So many! HIGH Nope. Passive GLUT2 Liver, Pancreas low NO! Passive GLUT3 So many! HIGH Nope. Passive GLUT4 Muscle, Fat tbd YES!! Passive GLUT5 GI tract Kidney Varies Yes Passive SGLT1 GI tract Kidney HIGH Yes ACTIVE SGLT2 GI tract Kidney low Yes ACTIVE INSULIN Released by cells of the pancreas in response to high glucose. Function is to promote the use of glucose by: Increasing GLUT 4: glycolysis ( gluconeogenesis), glycogen synthesis ( glyc bkdown), fatty acid synthesis and protein synthesis (their bkdown). It works by activating or inhibiting rate-limiting enzymes in these pathways or increasing or decreasing synthesis of these enzymes- posttranscriptional and transcriptional actions. GLUCAGON/ EPINEPHRINE Glucagon is made by the cells of the pancreas. Epi is made by the adrenals (later lecture). Glucagon is released in response to low blood glucose, Epi is response to stress. Their functions are to increase production of glucose especially for use by brain, RBC, muscle/heart. They do this by gluconeogenesis and glycogen/ fat/ protein breakdown. Basically the opposite of insulin shown previously. GLUCAGON works in liver & adipose, Epi-all tissues DIABETES Type 1-failure to produce insulin because of the destruction of the cells. Type II- failure to respond to the actions of insulin-insulin resistance. Associated with high blood glucose, impaired glucose utilization and high glucose production, bioenergetic problems/failure to thrive, ketosis b/c increased fatty acid metabolism , protein bkdown, glycosylation reactions and osmotic pressure GLYCOLYSIS C6H12O6 + 2 NAD+ 2 ADP + 2 Pi 2CH3COCOOH (pyruvate or pyruvic acid)+ 2 ATP + 2 NADH. Irreversible, occurs in cytosol of all cells. Pyruvate will be further metabolized Only source of energy for RBC, major source for embryonic tissue, retina, adrenals, some immune cells , exercising muscle. NOTE: need to regenerate NAD from NADH.
The 10 reactions of glycolysis Overall glycolysis reaction Glucose + 2NAD + + 2ADP + 2Pi
2Pyruvate + 2NADH + 2H + + 2ATP + 2H 2 O
= irreversible steps in glycolysis * 9 8 7 6 5 4 2 1 * 3 * * 10 Hexokinase VS Glucokinase Normal blood G conc 4-8 mM. 10-15mM after meals Glucose + ATP G6P + ADP Irreversible HK - low Km for G ( 0.1-1 mM), in all cells, by products G6P, ADP, reacts with other hexoses, not affected by insulin, glucagon, Epi GK- high Km for G ( 10 mM), in liver & pancreas, not affected by products, specific for G, mRNA levels by insulin,by glucagon & Epi PHOPHOFRUCTO-1-KINASE (PF-1K) F6P + ATP F1,6 Bis P + ADP Irreversible (+) allosteric effectors-AMP, Pi, NH4, F1,6 bis P (-) allosteric effectors- ATP, citrate MAJOR (+) effector is F2,6 Bis P F6P + ATP F2,6 Bis P + ADP F2,6 Bis P kinase RX F2,6 Bis P F6P + Pi F2,6 Bis P phophatase RX Insulin kinase butPhase. This will F2,6 and then PF-1K. Glucagon/ Epi kinase butPhase, this willF2,6 and then PF-1K. Covalent modif Step 3:
-F6P converted to fructose 1,6-bisphosphate (F16bP) -Enzyme: Phosphofructokinase -RATE LIMITING STEP -Requires ATP so irreversible -2 substrate binding sites -Inhibitors: ATP, citrate -Allosteric -Activators: AMP, P i , NH4 + , F16bP, (F26bP) -Allosteric -Also hormonal regulation -F6P goes into side rxn to make F26bP which is a major regulator of PFK -Insulin leads to dephosphorylation of F26kinase and F26phosphatase which means more F26bP is produced and PFK is upregulated -Insulin indicates fed state, it tells the body there is lots of glucose so it stimulates glycolysis to use this up -Glucagon/epi, via cAMP-PKA, promote phosphorylated inactive state of kinase and phosphorylated active state of phosphatase
1,3-bisphosphoglycerate ALDOLASE F1,6 Bis P G3P + DHAP DHAP can alpha glycero P, very important for triglyceride and phospholipid synthesis or G3P ( triose P isomerase RX) and continue glycolysis. Hence, F1,6 Bis P 2 G3P and we need to X by 2 all the next steps of glycolysis. NOTE: when F1,6 Bis P 2 G3P, C1 of the original G is equivalent to C6, C2and C5 cannot be distinguished and C3 and C4 cannot be discriminated from each other. Try to prove this. G3P DH REACTION G3P + NAD +Pi 1,3 Bis P glyceric acid + NADH 1,3 Bis PGA is a high energy compound. The next step ( PGK ) ATP: G3P + ADP 3PGA + ATP. This is substrate level phosphorylation no need for mito, ets, oxygen. Arsenic uncouples G3PDH by heavy metals-Hg, Cd,PB. We oxidized an aldehyde (G3P) to an acid (3PGA) in these 2 coupled steps. The energy was trapped as a high energy intermediate 1,3 Bis PGA, not released as heat if G3P 3PGA directly. 1,3 Bis PGA can be mutated to 2,3 Bis PGA (HB-O2)
Pyruvate Kinase PEP + ADP Pyr + ATP. Irreversible. PEP is a high energy compound. Substrate level phosphoryl. Requires monovalent cations like K or Na. PK ATP, NADH, Acetyl CoA and Glucagon- or epi- mediated Phosphorylation. by F1,6 Bis P and insulin stimulated dephosph. NOTE: ATP was made here & the G3P/ 3PGA coupled steps. We made 4 ATPs ( 2 per triose) and used 2 ATPs for the HK and PFK steps, net is 2 ATP/Glucose. FATES OF PYRUVATE RBC, exercising muscle, embryonic tissue lactate via lactate dehydrogenase (LDH) Yeast , conversion to ethanol via PDC & ADH Aerobic cells, conversion to acetyl CoA via PDH: Pyr + NAD+ CoA Acetyl CoA + CO2+ NADH FATES of Acetyl CoA CO2 via TCA Cycle, ATP; citrate which fatty acids ketones bodies,cholesterol, steroids Acetylation RX e.g histones Lactate Dehydrogenase Rxn: pyruvate+NADH+H + Lactate + NAD + Enzyme: lactate dehydrogenase (LDH) Reversible Anaerobic RBC have no mitochondria so this is their only way to get NADH reoxidized back to NAD + (req. for glycolysis, their only source of ATP) Net rxn: glucose +2ADP+Pi 2 lactate +2ATP LDH Tetramer: 2H & 2M chains o 5 isoforms:H4, H3M, H2M2, HM3 and M4 H4 and H3M: Brain or Heart M4 and M3H: RBC & skeletal muscle H subunits have high affinity for lactate &NAD + ; pyruvate --| H4
dehydrogenase Enzyme Name Cofactor Rxn E1 Pyruvate Decarboxylase Thiamine pyrophosphate (TPP) Oxidative decarboxylation of pyruvate E2 Dihydrolipoyl transacetylase Lipoamide Transfer of acetyl group to CoA E3 Dihydrolipoyl dehydrogenase Riboflavin (FAD) Regenerates Oxidized lipoamide Regulated enzyme Inhibited by Hormonal regulation E1 ATP PDH Kinase inhibits E1 PDH Phosphatase activates E1 and its action is increased by insulin E2 acetyl CoA E3 NADH Pyruvate Dehydrogenase Enzymes Product inhibition High energy signal inhibition TCA CYCLE In mito of all aerobic cells. IRREVERSIBLE Acetyl CoA + 3 NAD + FAD+ GDP+ Pi+ 2 H2O 2 CO2 +3 NADH+FADH2+GTP+CoASH ENERGETICS: 3 NADH 7.5 ATP; GTP=ATP FADH2 1.5 ATP 10 ATP/Acetyl CoA Of the 6 carbons in G, C3,4 CO2 in PDH RX C1,2,5,6CO2 in TCA cycle STEP 4 1.Kg + NAD + + CoA-SH Succinyl-CoA+ NADH + H +
+CO 2 1.Kg Dehydrogenase is a complex of enzymes 2.E1= Kg Decarboxylase has Thiamine PP as cofactor 1.inhibited by ATP 3.E2 = uses lipoic acid 1.inhibited by succinyl CoA 4.E3 = uses FAD & NAD to regenerate Lipoic acid 1.inhibited by NADH Step 5 1.Succinyl CoA + GDP +P i Succinate +CoA-SH + GTP 1.Enzyme = Succinyl CoA synthase (Thiokinase) 2.CEDERBAUM WORKED ON THIS enzyme (and he is adorable) Steps 6, 7 , and 8 1.Succinate + FAD Fumarate + FADH 2 1.Enzyme: Succinate dehydrogenase 2.Fumarate + H 2 0 Malate 1.Enzyme: Fumarase 3.Malate +NAD + OAA + NADH + H + 1.Enzyme: Malate dehydrogenase *each rxn is reversible but Malate dehydrogenase favors OAAMALATE ANAPLEROTIC (NOT EROTIC) RX Intermediates of the TCA cycle can be pulled out into other RX and pathways. OAA will not be regenerated , TCA stops. Anaplerotic RX are replenishing RX, fill in the pulled out intermediates. #1 in next slide is pyr carboxylase (PC), only in mito Not shown is the PEP carboxykinase RX: PEP + CO2+ GDP OAA + GTP (PEPCK in mito and/or cyto) PC & PEPCK very important for gluconeogenesis
Regulation of the TCA cycle Rate of electron transfer chain to reoxidize FADH2 & NADH. RESPIRATORY CONTROL ATP& NADH citrate synthase, ICDH, KGDH Concentration of and regeneration of OAA e.g OAA glucose, when G made, need toOAA Acetyl CoA is also produced from oxidation of fatty acids, several amino acids, ethanol so usually not limiting. Final Products 2 CO 2 s 1 FADH 2 (= 1.5 ATP) 3 NADH + 3H + (= 7.5 ATP) 1 GTP (= 1ATP) Total = 10 ATP/ Acetyl CoA OVERALL YIELD! Mitochondrial Carriers Carrier Description Phosphate exchanges Pi with OH Dicarboxylate exchanges Pi/malate/succinate for eachother Tricarboxylate
exchanges citrate, isocitrate, malate or PEP for eachother Alpha Ketoglutarate exchanges alphaKG for malate Pyruvate exchanges pyruvate for OH or ketone bodies Glutamate exchanges glutamate for OH Aspartate exchanges asparate for glutamate Adenine nucleotide exchanges ADP for ATP SHUTTLES NADH and NADPH cannot enter or leave mito Need substrate shuttles to transport them. Most imp. for NADH are the -glycerophosphate (GP) and malate-aspartate (MA) shuttles. These are also used for metabolism of other RX producing NAD(P)H e.g ethanol. Transamination is the transfer of an alpha amino of one amino acid to a keto acceptor to new aa and a new keto acceptor How to distinguish between the GP & MA shuttles Malate-Aspartate Shuttle Malate dehydrogenase Malate dehydrogenase Aspartate aminotransferase (GOT) Carriers 2, 3, 4 Carrier 7 Carrier 4 Aspartate aminotransferase (GOT) Cytosol Mitochondrial matrix Kg + CO 2 carrier 4 cyto ICDH mito ICDH carrier 3 isocitrate isocitrate NADP + NADPH NADP + NADPH NAD + NADH trans hydro- genase Kg + CO 2 GLYCOGEN METABOLISM Glycogen a storage form of G, made up of many G units linked by 1C of one G to the C4 of another G. Also C1 to C6 links make branches. Glycogen made under high- energy, carbs & G Glycogen broken down low- energy, carbs & G : vigorous exercise/ stress: diabetes Stored mainly in liver and muscle. Function of liver Glyc is to produce G for use by other tissues needing energy. Function of muscle Glyc is to produce G for use of muscle itself Glycogen Breakdown Catalyzed by phosphorylase and debranching enzyme many G1P + 1 G where a branchpoint G1PG6P via phosphoglucomutase G6PG via G6Pase in liver OR glycolysis in muscle. Note that G6Pase is by glucagon/Epi Phosphorylase is activated when P by phosphorylase kinase (PK) which itself is activated by cAMP-dependent PKA. Thus glucagon in liver and Epi in liver and muscle Glyc breakdown. Insulin promotes the deP state of PK and phosphorylase which activities Glycogen Synthesis GG6PG1PUDPG. Need exisiting primer- Glycogen (n) + UDPG Glycogen ( n+1) + UDP Catalyzed by Glyc Synthase ( GS) and Branching enzyme GS active in de P state (GS-OH) and inactive when P (GS-OP). Insulin, via protein phosphatase 1 (PP1) promotes the de P state while cAMP PKA promotes the P state. Same with PK and phosphorylase. Note deP state GS and Glyc synthesis but PK and Glyc breakdown-insulin while P state PK and Phosphoryalse & Glyc breakdown, but GS Glucaon/Epi MORE GLYCOGEN REGULATION I am kind of tired. Need coffee,a PDE inhibitor AMP Phos-OH ( low activity) which will activity a bit and some Glyc breakdown. ATP & G6PPhos-OH G6P GS-OP ( low activity) which will some Glyc synthesis Glucaon/Epi PP1 by P and also by activity of a PP1 inhibitor by P. InsulinPP1 by deP and by also by inactivating the PP1 inhibitor. Liver Phos is a glucose sensor-binds PP1 when G is not present so PP1 not effective but releases PP1 when G is present so now PP1 starts to do its job F2,6 Bis P in liver VS Muscle Why didnt the G6P made from glycogen glycolysis in the liver but did in the muscle? Recall, F2,6 bis P was the major (+) effector of PF- 1K. Its production was by insulin which the F2,6 kinase but the F2,6 bis Phase by covalent modifications. Glucagon/ Epi in liver the kinase &the Phase so F2,6 levels & glycolysis. In muscle, different isoforms of the kinase and Phase exist than in liver such that Epi the kinase &Phase,therebyF2,6 BisP &PF-1K Liver Muscle Glucose tissues Glucose glycolysis Glucagon + Epi stimulate glycogen phosphorylase Epi stimulates glycogen phosphorylase Epi stimulates G6Pase Glucagon + Epi decrease F26bP so glycolysis decreased Epi increases F26bP so glycolysis increased Phosphorylation decreases F26bP kinase and increases phosphatase activity Phosphorylation increases F26bP kinase and decreases phosphatase activity
Phosphorylase: glucose sensor. No glucose: phosphorylase binds protein phophatase 1 =>prevents deP=> active Phosphorylase, inactive synthase (no glycogen synthesis!) and vice versa!
The liver and muscle isoforms of F2,6-bP kinase and phosphatase are opposites. For more detailed info on this see the last text page of Cederbaums lecture. PENTOSE P PATHWAY Function s to produce NADPH, ribose 5 P, interconversions of C3,C4, C5, C6 and C7 sugars. Active in cytosol of liver, RBC, adipose, adrenals, mammary tissue Regulated by Conc. of G6P, NADP/NADPH. Insulin small G6PDH First 2 steps catalyzed by G6PDH & 6PGADH- IRREV 3 G6P3CO2+6 NADPH +3Ribulose 5P. Step 3 is 3 Ribulose 5P3 Ribose 5P PPIsomerase-REVERSIBLE. Rearrangements: Transketolase,Transaldolase,Transketolase RX 3 Ribose 5P2F6P+ G3P(=0.5 G6P); 2.5 G6P made. TPP cofactor for TK NOTE G6P & G3P can R5P by reversing Rearrangement RX CO2 came off C1 of G6P, can come off other Cs after rearrangement REARRANGEMENT RXs a) 3 G6P + 6 NADP + 3 CO 2 + 6 NADPH + 3 Ribulose 5P (G6PDH and 6-PGADH steps) b) 1 Ribulose 5P 1 Ribose 5P (phosphopentoisomerase rxn) c) 2 Ribulose 5 P 2 Xylulose 5P(phosphopentoepimerase rxn) d) Ribose 5P + Xylulose 5P Glyceraldehyde 3P + Sedoheptulose 7P ( 1 st transketolase rxn) (C5) + (C5) (C3) + (C7) e) Glyceraldehyde 3P + Sedoheptulose 7P Erythrose 4P + Fructose 6-P (transaldolase rxn) (C3) + (C7) (C4) + (C6) f) Erythrose 4 P + the second Xylulose 5P from rxn (c) Glyceraldehyde 3P + Fructose 6P (C4) + (C5) (C3) + (C6) ( second transketolase rxn
NET RX: a) 3 G6P + 6 NADP+ 3 CO 2 + 6 NADPH + 3 Ribulose 5P (G6PDH and 6-PGADH steps)) (b f) 3 Ribulose 5P 2.5 G6P rearrangements Net 6NADP + + 0.5 G6P 3 CO 2 + 6 NADPH
OXIDATIVE STRESS & PPP Hydrogen peroxide, H2O2,made in aerobic cells from mito ets or autooxidation of ferrous hemes like hemoglobin. H2O2 removed by catalase and by glutathione peroxidase, GPX, which uses glutathione,GSH, a tripeptide. H2O2 + 2 GSH 2 H2O + GSSG GPX RX Note GSH is oxidized to GSSG and must be reduced back to GSH by glutathione reductase GSSG + 2NADPH2 GSH +2 NADP G6PDH DEFICIENCY Most common inborn error of metabolism Complete deficiency is embryonic lethal. Certain drugs G6PDH, can RBC hemolysis, anemia. Those with low G6PDH sensitive to oxidant stress produced by drugs, chemicals, foods (Fava beans), high O2, high altitudes Wernicke Korsakoff Syndrome- poor memory, orientation,gait, mental function/ neuropsyc. Disorders. Due to 10X in Km for TPP by TK GLUCONEOGENESIS Occurs with low G/CH diet,fasting/starvation,when G is needed for quick & rapid energy for muscle. Liver & kidney. Compartmentalized cyto & mito. Most common substrates-lactate & aapyr. 2 Pyr+ 2 GTP +4 ATP+ 2 NADHG + 2 GDP+ 4 ADP + 2 NAD + 6 Pi. Where is energy from? Most, but not all, steps are reversal of glycolysis. To bypass PK, PF-1K, & GK/HK, need gluconeo enzymes PC, PEPCK, F1,6 Bis Phase, G6Pase These are by glucagon/Epi and by insulin. Step 2&3: Pyruvate OAA PEP Pyruvate converted to PEP via two steps to bypass the irreversible pyruvate kinase reaction Step 2: Pyruvate carboxylase reaction Pyruvate + ATP + CO2 OAA + ADP +Pi Happens in mito Step 3: PEP carboxykinase (PEPCK) reaction OAA + GTP PEP + CO2 + GDP Happens in mito and cytosol Step 6&7: F6P G6P glucose - F1,6 bis phosphatase: stimulated by low energy signals (AMP, Pi, NH4+, glucagon, epi) and inhibited by high energy signals (ATP, citrate, insulin) - G6Pase: stimulated by glucagon and epi, inhibited by insulin CORI CYCLE or exercising muscle REGULATION FATTY ACIDS Functions: Major source of energy for most tissues but not RBC or brain Major storage from of energy as triglycerides Make up phospholipids & glycolipids of biological membranes Produce signal transduction molecules e.g inositol Phosphates, Diacylglycerol Produce prostaglandins, leukotrienes
FA OXIDATION Palmitoyl CoA: C16+7 FAD+7 NAD+7CoA+7H2O 8 Acetyl CoA +7 FADH2 + 7 NADH: Energetics: 8 Acetyl CoA 80 ATP 7 FADH2 10.5 ATP 7 NADH17.5 ATP Total 108 ATP made 2 ATP to activate =106ATP
Occurs in Mito & some in peroxisomes -oxidation pathway Step 1: Fatty acid fatty acyl CoA via Acyl CoA synthase in mitochondria Short and medium chains enter mito directly; long chains utilize carnitine transporter -oxidation pathway 4 enzyme catalyzed reactions to remove 2 carbon fragment at a time produce acetyl CoA plus a new fatty acyl CoA shortened by 2 carbon atoms Acetyl CoA can then enter Kreb cycle Repeats until all the carbons are oxidized to acetyl CoA Each round produces: one FADH2 and one NADH Ex. C18 fatty acid will undergo 8 rounds ODD CHAIN FA Basically same as even chain FA- -oxidation of C17 FA CoA 7 Acetyl CoA +Propionyl CoA CH3CH2COCoA+ CO2D-MethylmalonylCoA via propionyl CoA Carboxylase ( Biotin) L-MMCoA via MMA racemase Succinyl CoA via MMA Mutase. Mutase requires deoxyadenosyl B12 to catalyze this remarkable rearrangement RX Will return to this in our B12 lecture Regulation of -oxidation Availability of fatty acids via activated hormone sensitive lipase Availability of carnitine. Malonyl CoA, the product of the rate-limiting enzyme of fatty acid synthesis (next lecture) inhibits carnitine acyl transferases 1 and 2. Rate of the electron transport chain Q: Explain possible major problems for patients A, B, C in oxidizing palmitate into CO2: Substrate Rate of CO2 Production Control A B C Palmitate 100% 10% 10% 10% Palmitoyl-coA 100% 100% 10% 10% Palmitoyl- Carnitine 100% 100% 100% 10% Acetyl-coA 100% 100% 100% 100% FA SYNTHESIS 8 Acetyl CoA+ 7ATP+ 14NADPH C16 palmitoyl CoA+7CoA +7ADP+7Pi + 14NADP Compartmentalized between Mito & Cyto Acetyl CoA from Pyr ( G) & AA ( not from FA) NADPH from PPP, Transhydro & isocit shuttle & malic enzyme Substrates and Metabolic Conditions Activating conditions High glucose High protein Insulin Activates SREBP Inhibiting conditions Glucagon Inhibits SREBP Malonyl CoA Inhibits acyl carnitine transferase that brings FA into mito for B-oxidation Location Cytoplasm of most cells especially liver Substrate Acetyl CoA (transported to cytoplasm as citrate from glycolysis) Energy demands ATP and NADPH
Rate Limiting Step Acetyl CoA + ATP + CO 2 malonyl CoA + ADP + P i Enzyme: Acetyl CoA carboxylase Cofactor: biotin Activators: Citrate Insulin (dephos ACC and stimulating it) Inhibitors: palmitoyl CoA (product) AMP activated kinase (phosphorylates ACC) Glucagon/cAMP-PKA (phosphorylates ACC at another site) REGULATION Many of the lipogenic enzymes ACC, FAS, ATP- citrate lyase, malic enzyme are induced by insulin which activates processing of the master transcriptional activator Sterol Regulatory Element Binding Protein (SREBP)to its active form. High glucose activates Carbohydrate Response Element Binding Protein which upregulates many genes involved in carbo and FA synthesis ( JC paper). FATTY ACID OXIDATION Three patients(ABC)have trouble ox Palm to CO2 CONTROL A B C SUBSTRATE RATE OF CO2 PRODUCTION Palmitate 100 10 10 10 Palm CoA 100 100 10 10 Palm Carnitine 100 100 100 10 Acetyl CoA 100 100 100 100 Fed State Basal State Starved State